Pretreatment inflammatory indices predict Bevacizumab response in recurrent Glioma

  1. Martínez-González, A.
  2. Cabrera, R.
  3. Lloret, M.
  4. Lara, P.C.
Revue:
Cancer Drug Resistance

ISSN: 2578-532X

Année de publication: 2020

Volumen: 3

Número: 3

Pages: 623-635

Type: Article

DOI: 10.20517/CDR.2020.33 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus